DP635 TOURO LA-LD (Touro LA-LD 525 mg / 50 mg)
Generic Name: guaifenesin/pseudoephedrine
Pill with imprint DP635 TOURO LA-LD has been identified as Touro LA-LD 525 mg / 50 mg. It is supplied by Dartmouth Pharmaceuticals Inc.
Touro LA-LD is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Touro LA-LD 525 mg / 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DP635 TOURO LA-LD
Touro LA-LD
- Generic Name
- guaifenesin/pseudoephedrine
- Imprint
- DP635 TOURO LA-LD
- Strength
- 525 mg / 50 mg
- Availability
- Rx and/or OTC
- Drug Class
- Upper respiratory combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dartmouth Pharmaceuticals Inc
- National Drug Code (NDC)
- 58869-0635 (Discontinued)
More about Touro LA-LD (guaifenesin / pseudoephedrine)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Imprints, shape & color data
- Drug class: upper respiratory combinations
Patient resources
- Other brands
- Mucinex D, Pseudovent, Mucinex D Maximum Strength, Entex PSE, ... +11 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.